Blog

Paul Kelly: The role of Space OAR Vue in modifying the risk of rectal side effects

Paul Kelly/www.corkbeo.ie

Oct 13, 2024, 22:29

Paul Kelly: The role of Space OAR Vue in modifying the risk of rectal side effects

Paul Kelly, Radiation Oncologist at Bon Secours Hospital Cork UPMC, Ireland shared a post by Karen Molan, Senior Clinical Researcher at on X, adding:

“Great to make a contribution to this prostate cancer radiotherapy SBRT clinical trial, the subject of which is the role of Boston Scientific EMEA – Urology Space OAR Vue in modifying the risk of rectal side effects.

Patients are never the barrier to clinical trial recruitment.”

Quoting Karen Molan:

“Trial Activity.
SABRE Trial Achievement
20 Patients recruited.”

Boston Scientific EMEA - Urology cancer cancer awareness cancer care CancerTrialsIreland fight against cancer Global fight against cancer OncoDaily Oncology Paul Kelly prostate cancer prostate cancer radiotherapy QOL radiotherapy SABR SBRT clinical trial

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer